Flumazenil intravenous（Expansion Therapeutics）
氟马西尼静脉注射剂（Expansion Therapeutics）
Report date: 2025/04/30 20:00:42
Base Information
Drug NameFlumazenil intravenous（Expansion Therapeutics）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesExpansion Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesExpansion Therapeutics Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A